Cocrystal Discovery Lands $7,500,000 New Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0693c826-0130-4ccb-afe7-4bd7568bb584&Preview=1 -
Date
9/15/2011 -
Company Name
Cocrystal Discovery -
Mailing Address
19805 North Creek Parkway Bothell, WA 98011 -
Company Description
Cocrystal Discovery, Inc. is a privately funded biotechnology company developing antiviral therapeutics for human diseases. Cocrystal has breakthrough technologies that enable the creation of first- and best-in-class antivirals. Our mission today is to discover and develop small molecule inhibitors of the viral replication complex. Viral diseases represent one of the world’s largest and greatest unmet medical needs. We are currently focusing on: Hepatitis C virus, Influenza virus, Rhinovirus (common cold). -
Website
http://www.cocrystaldiscovery.com -
Transaction Type
Venture Equity -
Transaction Amount
$7,500,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
This investment will be utilized by CDI to continue its development program of novel antiviral drugs that target viral replication enzymes. -
M&A Terms
-
Venture Investor
Teva Pharmaceutical Industries
